TY - JOUR
T1 - Posterior circumflex humeral artery pathology and digital ischemia in elite volleyball: Symptoms, risk factors & suggestions for clinical management
AU - van de Pol, Daan
AU - Kuijer, P. Paul F. M.
AU - Terpstra, Aart
AU - Pannekoek-Hekman, Marja
AU - Alaeikhanehshir, Sena
AU - Bouwmeester, Olivier
AU - Planken, R. Nils
AU - Maas, Mario
PY - 2018
Y1 - 2018
N2 - Objectives: To assess the association between posterior circumflex humeral artery (PCHA) pathology (PCHAP), symptoms and associated risk factors, in elite volleyball players, and to suggest profiles for clinical management and monitoring. Design: Cross-sectional study. Methods: A questionnaire assessed symptoms of digital ischemia (DI) in the dominant hand and risk factors among 278 elite indoor and beach volleyball players of whom 6.1% (17/278) was diagnosed with PCHAP using ultrasound. Odds Ratios (OR) including 95% confidence intervals (95%CI) were calculated using binary logistic regression. Results: All 278 players completed the questionnaire. Three participants with PCHAP were symptomatic (18%). Ninety-three of 96 symptomatic participants had no PCHAP (OR = 0.39; 95% CI 0.13–1.13). Total years playing volleyball (OR 1.14; 95% CI 1.03–1.25) and age (OR 1.17; 95% CI 1.00–1.29) were dose-response related risk factors: a volleyball career of ≥17 years and age of ≥27 years were associated with a 9-fold and 14-fold increased risk of PCHAP, respectively. Conclusions: The volleyball career duration and age are dose-response related risk factors for PCHAP among elite indoor and beach volleyball players. DI symptoms are prevalent in a minority of athletes with PCHAP (3/17; 18%). To enable worldwide standardized care for these athletes at risk, four profiles for clinical management and monitoring have been suggested based on questionnaire and ultrasound outcomes.
AB - Objectives: To assess the association between posterior circumflex humeral artery (PCHA) pathology (PCHAP), symptoms and associated risk factors, in elite volleyball players, and to suggest profiles for clinical management and monitoring. Design: Cross-sectional study. Methods: A questionnaire assessed symptoms of digital ischemia (DI) in the dominant hand and risk factors among 278 elite indoor and beach volleyball players of whom 6.1% (17/278) was diagnosed with PCHAP using ultrasound. Odds Ratios (OR) including 95% confidence intervals (95%CI) were calculated using binary logistic regression. Results: All 278 players completed the questionnaire. Three participants with PCHAP were symptomatic (18%). Ninety-three of 96 symptomatic participants had no PCHAP (OR = 0.39; 95% CI 0.13–1.13). Total years playing volleyball (OR 1.14; 95% CI 1.03–1.25) and age (OR 1.17; 95% CI 1.00–1.29) were dose-response related risk factors: a volleyball career of ≥17 years and age of ≥27 years were associated with a 9-fold and 14-fold increased risk of PCHAP, respectively. Conclusions: The volleyball career duration and age are dose-response related risk factors for PCHAP among elite indoor and beach volleyball players. DI symptoms are prevalent in a minority of athletes with PCHAP (3/17; 18%). To enable worldwide standardized care for these athletes at risk, four profiles for clinical management and monitoring have been suggested based on questionnaire and ultrasound outcomes.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85044972423&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/29628407
U2 - https://doi.org/10.1016/j.jsams.2018.03.010
DO - https://doi.org/10.1016/j.jsams.2018.03.010
M3 - Article
C2 - 29628407
SN - 1440-2440
VL - 21
SP - 1032
EP - 1037
JO - Journal of science and medicine in sport / Sports Medicine Australia
JF - Journal of science and medicine in sport / Sports Medicine Australia
IS - 10
ER -